期刊文献+
共找到22篇文章
< 1 2 >
每页显示 20 50 100
Polycomb Repressive Complex 2-Mediated H3K27 Trimethylation Is Required for Pathogenicity in Magnaporthe oryzae 被引量:2
1
作者 WU Zhongling QIU Jiehua +7 位作者 SHI Huanbin LIN Chuyu YUE Jiangnan LIU Zhiquan XIE Wei Naweed INAQVI KOU Yanjun TAO Zeng 《Rice science》 SCIE CSCD 2022年第4期363-374,共12页
Polycomb repressive complex 2(PRC2)contributes to catalyze the methylation of histone H3 at lysine 27 and plays vital roles in transcriptional silencing and growth development in various organisms.In Magnaporthe oryza... Polycomb repressive complex 2(PRC2)contributes to catalyze the methylation of histone H3 at lysine 27 and plays vital roles in transcriptional silencing and growth development in various organisms.In Magnaporthe oryzae,histone H3K27 is found to associate with altered transcription of in planta induced genes.However,it is still unknown whether and how H3K27me3 modification is involved in pathogenicity to rice and stress response.In this study,we found that core subunits of PRC2,Kmt6-Suz12-Eed,were required for fungal pathogenicity to rice in M.oryzae.Kmt6-Suz12-Eed localized in the nuclei and was necessary for the establishment of H3K27me3 modification.With ChIP-seq analysis,9.0%of genome regions enriched with H3K27me3 occupancy,which corresponded to 1033 genes in M.oryzae.Furthermore,deletion of Kmt6,Suz12 or Eed altered genome-wide transcriptional expression,while the de-repression genes in theΔkmt6 strain were highly associated with H3K27me3 occupancy.Notably,plenty of genes which encode effectors and secreted enzymes,secondary metabolite synthesis genes,and cell wall stress-responsive genes were directly occupied with H3K27me3 modification and de-repression in theΔkmt6 strain.These results elaborately explained how PRC2 was required for pathogenicity,which is closely related to effector modulated host immunity and host environment adaption. 展开更多
关键词 rice blast H3K27me3 transcriptional regulation PATHOGENICITY polycomb repressive complex 2
在线阅读 下载PDF
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment 被引量:1
2
作者 Irene Marchesi Luigi Bagella 《World Journal of Clinical Oncology》 CAS 2016年第2期135-148,共14页
Polycomb group proteins represent a global silencing system involved in development regulation.In specific,they regulate the transition from proliferation to differentiation,contributing to stem-cell maintenance and i... Polycomb group proteins represent a global silencing system involved in development regulation.In specific,they regulate the transition from proliferation to differentiation,contributing to stem-cell maintenance and inhibiting an inappropriate activation of differentiation programs.Enhancer of Zeste Homolog 2(EZH2) is the catalytic subunit of Polycomb repressive complex 2,which induces transcriptional inhibition through the tri-methylation of histone H3,an epigenetic change associated with gene silencing.EZH2 expression is high in precursor cells while its level decreases in differentiated cells.EZH2 is upregulated in various cancers with high levels associated with metastatic cancer and poor prognosis.Indeed,aberrant expression of EZH2 causes the inhibition of several tumor suppressors and differentiation genes,resulting in an uncontrolled proliferation and tumor formation.This editorial explores the role of Polycomb repressive complex 2 in cancer,focusing in particular on EZH2.The canonical function of EZH2 in gene silencing,the non-canonical activities as the methylation of other proteins and the role in gene transcriptional activation,were summarized.Moreover,mutations of EZH2,responsible for an increased methyltransferase activity in cancer,were recapitulated.Finally,various drugs able to inhibit EZH2 with different mechanism were described,specifically underscoring the effects in several cancers,in order to clarify the role of EZH2 and understand if EZH2 blockade could be a new strategy for developing specific therapies or a way to increase sensitivity of cancer cells to standard therapies. 展开更多
关键词 enhancer of ZESTE HOMOLOG 2 polycomb group proteins HISTONE METHYLTRANSFERASE enhancer of ZESTE HOMOLOG 2 inhibitors Anticancer drugs Cancer therapy Epigenetics
暂未订购
Role of H3K27 methylation in the regulation of IncRNA expression 被引量:22
3
作者 Susan C Wu 《Cell Research》 SCIE CAS CSCD 2010年第10期1109-1116,共8页
Once thought to be transcriptional noise, large non-coding RNAs (IncRNAs) have recently been demonstrated to be functional molecules. The cell-type-specific expression patterns of lncRNAs suggest that their transcri... Once thought to be transcriptional noise, large non-coding RNAs (IncRNAs) have recently been demonstrated to be functional molecules. The cell-type-specific expression patterns of lncRNAs suggest that their transcription may be regulated epigenetically. Using a custom-designed microarray, here we examine the expression profile of IncRNAs in embryonic stem (ES) cells, lineage-restricted neuronal progenitor cells, and terminally differentiated fibroblasts. In addition, we also analyze the relationship between their expression and their promoter H3K4 and H3K27 methyla- tion patterns. We find that numerous lncRNAs in these cell types undergo changes in the levels of expression and promoter H3K4me3 and H3K27me3. Interestingly, lncRNAs that are expressed at lower levels in ES cells exhibit higher levels of H3K27me3 at their promoters. Consistent with this result, knockdown of the H3K27me3 methyltransferase Ezh2 results in derepression of these IncRNAs in ES cells. Thus, our results establish a role for Ezh2-mediated H3K27 methylation in lncRNA silencing in ES cells and reveal that lncRNAs are subject to epigenetic regulation in a similar manner to that of the protein-coding genes. 展开更多
关键词 IncRNA histone methylation polycomb repressive complex 2
在线阅读 下载PDF
Inhibition of SIRT1 Increases EZH2 Protein Level and Enhances the Repression of EZH2 on Target Gene Expression
4
作者 Chih-chuan Liang 《Chinese Medical Sciences Journal》 CAS CSCD 2011年第2期77-84,共8页
Objective To study the regulatory roles of SIRT1 on EZH2 expression and the further ef-fects on EZH2's repression of target gene expression. Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were establish... Objective To study the regulatory roles of SIRT1 on EZH2 expression and the further ef-fects on EZH2's repression of target gene expression. Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were established by in-fection with retroviruses expressing shSIRT1 and shLuc respectively followed by puromycin selection. EZH2 protein level was detected by Western blot in either whole cell lysate or the fractional cell extract. Reverse transcription-polymerase chain reaction was performed to detect the mRNA level of EZH2. Cycloheximide was used to treat SIRT1 RNAi and Control RNAi cells for protein stability assay. Chromatin immunoprecipitation (ChIP) assay was applied to measure enrichment of SIRT1, EZH2, and trimethylated H3K27 (H3K27me3) at SATB1 promoter in SIRT1 RNAi and Control RNAi cells. Results Western blot results showed that EZH2 protein level increased upon SIRT1 de-pletion. Fractional extraction results showed unchanged cytoplasmic fraction and increased chromatin fraction of EZH2 protein in SIRT1 RNAi cells. The mRNA level of EZH2 was not affected by knockdown of SIRT1. SIRT1 recruitment was not detected at the promoter region of EZH2 gene locus. The protein stability assay showed that the protein stability of EZH2 increases upon SIRT1 knockdown. Upon SIRT1 depletion, EZH2 and H3K27me3 recruitment at SATB1 promoter increases and the mRNA level of SATB1 decreases. Conclusions Depletion of SIRT1 increases the protein stability of EZH2. The regulation of EZH2 protein level by SIRT1 affects the repressive effects of EZH2 on the target gene expres-sion. 展开更多
关键词 SIRT1 EZH2 polycomb repression complex trimethylated H3K27
在线阅读 下载PDF
TRIM25通过EZH2介导巨噬细胞M2极化促进食管鳞状细胞癌细胞的增殖迁移和侵袭
5
作者 张诗彤 田新春 +1 位作者 花海洋 刘洪运 《河北医学》 CAS 2024年第3期416-423,共8页
目的:探讨TRIM25和EZH2在食管鳞状细胞癌(ESCC)相关巨噬细胞浸润中的作用及其可能的作用机制。方法:利用佛波酯诱导THP-1为M0巨噬细胞,将其与转染处理后的KYSE510细胞共培养,收集共培养巨噬细胞,分为Ctrl组、sh-NC组、sh-TRIM25组、sh-N... 目的:探讨TRIM25和EZH2在食管鳞状细胞癌(ESCC)相关巨噬细胞浸润中的作用及其可能的作用机制。方法:利用佛波酯诱导THP-1为M0巨噬细胞,将其与转染处理后的KYSE510细胞共培养,收集共培养巨噬细胞,分为Ctrl组、sh-NC组、sh-TRIM25组、sh-NC+oe-NC组、sh-TRIM25+oe-NC组、sh-NC+oe-EZH2组和sh-TRIM25+oe-EZH2组。收集共培养上清液,将其加入KYSE510细胞中,分为Ctrl组、TAM组、sh-NC+TAM组、sh-TRIM25+TAM组、sh-NC+oe-NC+TAM组、sh-TRIM25+oe-NC+TAM组、sh-NC+oe-EZH2+TAM组和sh-TRIM25+oe-EZH2+TAM组。qPCR法和WB法检测细胞中TRIM25、EZH2和Arg-1表达,放线菌酮蛋白合成抑制实验检测细胞EZH2蛋白稳定性,FCM检测F4/80+CD206+巨噬细胞比例,CCK-8法、克隆形成实验和Transwell实验分别检测细胞的增殖、迁移和侵袭能力。结果:KYSE510细胞中TRIM25和EZH2 mRNA和蛋白表达均高于人食管鳞状上皮细胞HET-1A(P<0.01)。与sh-NC组和sh-NC+oe-NC组相比,sh-TRIM25组和sh-TRIM25+oe-NC组F4/80+CD206+巨噬细胞比例和Arg-1蛋白表达均降低(P<0.05),sh-NC+oe-EZH2组则升高(P<0.05)。与sh-NC+TAM组和sh-NC+oe-NC+TAM组相比,sh-TRIM25+TAM组和sh-TRIM25+oe-NC+TAM组KYSE510细胞活力、克隆形成数、迁移和侵袭细胞数均降低(P<0.05),sh-NC+oe-EZH2+TAM组则升高(P<0.05)。敲低TRIM25可通过抑制EZH2蛋白半衰期,降低EZH2蛋白稳定性。过表达EZH2可部分逆转sh-TRIM25对巨噬细胞和KYSE510细胞的影响。结论:TRIM25通过促进EZH2蛋白稳定性诱导巨噬细胞M2极化,从而促进ESCC细胞增殖、迁移和侵袭。 展开更多
关键词 食管鳞状细胞癌 TRIM25 EZH2 KYSE510细胞 巨噬细胞
暂未订购
长链非编码RNA Hotair在CKD小鼠肾脏纤维化中的作用及机制研究
6
作者 刘琳 任燕 +1 位作者 陈茂盛 王敏敏 《浙江医学》 CAS 2023年第22期2357-2362,I0003,共7页
目的探讨长链非编码RNA(lncRNA)Hotair在慢性肾脏病(CKD)小鼠模型肾脏纤维化中的作用及其机制。方法采用随机数字表法将36只小鼠分为对照组、CKD组、CKD+短发夹RNA-对照(sh-Ctrl)组、CKD+短发夹RNA-Hotair(shHotair)组,每组9只。对照组... 目的探讨长链非编码RNA(lncRNA)Hotair在慢性肾脏病(CKD)小鼠模型肾脏纤维化中的作用及其机制。方法采用随机数字表法将36只小鼠分为对照组、CKD组、CKD+短发夹RNA-对照(sh-Ctrl)组、CKD+短发夹RNA-Hotair(shHotair)组,每组9只。对照组喂食正常饲料,其余3组均予0.2%腺嘌呤饲料喂养造模。造模6周后,CKD+sh-Ctrl组和CKD+shHotair组分别予尾静脉注射100μL(10^(11)基因拷贝)包装了对照shRNA和Hotair-shRNA的腺相关病毒,对照组和CKD组予尾静脉注射100μL 0.9%氯化钠注射液。观察8周后处死,检测血清肌酐、尿素氮水平,取肾组织行HE染色和Masson染色观察肾脏纤维化情况。采用qRT-PCR法检测肾皮质Hotair、多梳抑制复合体2(PRC2)复合物[Zeste增强子同源物2(EZH2)、Zeste12同源物抑制因子(SUZ12)、胚胎外胚层发育蛋白(EED)]和赖氨酸特异性去甲基化酶1(LSD1)mRNA表达水平,Western blot法检测肾皮质纤维化相关蛋白胶原蛋白1A1(COL1A1)、胶原蛋白4A1(COL4A1)、α-平滑肌肌动蛋白(α-SMA)和E-钙黏蛋白(E-cadherin)的表达水平,并检测PRC2复合物和LSD1的蛋白表达水平。结果与对照组比较,CKD组小鼠体重下降、肾功能恶化,出现肾脏纤维化,肾皮质Hotair表达升高;与CKD+sh-Ctrl组比较,CKD+sh-Hotair组小鼠血清肌酐、尿素氮水平均降低(均P<0.01),病理检查显示肾脏纤维化程度减轻,肾皮质Hotair表达下降(P<0.01)。与对照组比较,CKD组小鼠COL1A1、COL4A1和α-SMA蛋白表达水平均增加,E-cadherin表达水平减少,PRC2复合物中EZH2、EED和LSD1 m RNA和蛋白表达水平均升高(均P<0.01)。与CKD+sh-Ctrl组比较,CKD+sh-Hotair组小鼠COL1A1、COL4A1和α-SMA蛋白表达水平均降低,E-cadherin蛋白表达水平恢复,PRC2复合物中EZH2、EED和LSD1 mRNA和蛋白表达水平均下降(均P<0.01)。结论lncRNA Hotair在CKD小鼠模型中表达升高,敲低Hotair可缓解肾脏纤维化,可能与Hotair作为PRC2和LSD1的分子支架介导的表观遗传修饰相关。 展开更多
关键词 长链非编码RNA Hotair 慢性肾脏病 纤维化 PRC2复合物
暂未订购
MIF、PRC2核心基因、p27在胃癌合并Hp感染患者病变组织中的表达及其临床意义 被引量:8
7
作者 晏勇 文黎明 +2 位作者 秦佳敏 杨亚玲 许婷婷 《现代生物医学进展》 CAS 2021年第14期2758-2763,共6页
目的:探究巨噬细胞移动抑制因子(MIF)、多梳抑制复合物2(PRC2)核心基因(EZH2)、p27在胃癌合并Hp感染患者病变组织中的表达情况及其临床意义。方法:选取我院2017年6月2019年2月期间接治的68例胃癌合并Hp感染患者作为胃癌合并Hp感染组,另... 目的:探究巨噬细胞移动抑制因子(MIF)、多梳抑制复合物2(PRC2)核心基因(EZH2)、p27在胃癌合并Hp感染患者病变组织中的表达情况及其临床意义。方法:选取我院2017年6月2019年2月期间接治的68例胃癌合并Hp感染患者作为胃癌合并Hp感染组,另选取54例单纯胃癌患者作为单纯胃癌组,比较两组癌组织与癌旁组织中MIF、EZH2、p27表达水平的差异,并对比胃癌合并Hp感染组不同临床病理特征患者MIF、EZH2、p27表达情况,采用Spearman相关性分析MIF、EZH2、p27与胃癌、胃癌合并Hp感染及临床病理特征的关联性。对胃癌合并Hp感染组随访1年,统计1年生存率,采用Kaplan-Meier曲线对胃癌合并Hp感染组不同MIF、EZH2、p27表达患者的生存情况生存分析。结果:两组癌组织中MIF、EZH2阳性表达率高于癌旁组织,p27阳性表达率低于癌旁组织,胃癌合并Hp感染组癌组织、癌旁组织中MIF、EZH2高于单纯胃癌组,p27阳性表达率低于单纯胃癌组(P<0.05);Spearman相关性分析,MIF、EZH2与胃癌合并Hp感染患者TNM分期、淋巴结转移呈正相关,与分化程度呈负相关,p27与胃癌合并Hp感染患者TNM分期、淋巴结转移呈负相关,与分化程度呈正相关(P<0.05)。结论:MIF、EZH2、p27在胃癌合并Hp感染患者病变组织中呈异常表达,与TNM分期、淋巴结转移、分化程度密切相关,且MIF、p27能为临床预测生存状况提供参考依据。 展开更多
关键词 胃癌 幽门螺杆菌感染 巨噬细胞移动抑制因子 多梳抑制复合物2核心基因 P27 病理特征 生存状况
原文传递
靶向PRC2相关蛋白小分子抑制剂的研究进展 被引量:1
8
作者 顾婧 郭小可 尤启冬 《药学学报》 CAS CSCD 北大核心 2020年第8期1726-1734,共9页
多梳抑制复合物(polycomb repressive complex 2,PRC2)的异常表达与多种疾病的形成、发展相关,抑制正常或过度活跃的PRC2可以在几种癌症中降低细胞存活率并抑制肿瘤生长,因此,相关小分子抑制剂的研发成为了当前表观遗传学相关抗肿瘤策... 多梳抑制复合物(polycomb repressive complex 2,PRC2)的异常表达与多种疾病的形成、发展相关,抑制正常或过度活跃的PRC2可以在几种癌症中降低细胞存活率并抑制肿瘤生长,因此,相关小分子抑制剂的研发成为了当前表观遗传学相关抗肿瘤策略的热点领域。靶向enhancer of zeste homologue 2(EZH2)的S-腺苷-L-甲硫氨酸(S-adenosyl-L-methionine,SAM)结合位点的小分子抑制剂中已有药物经过FDA批准上市,然而,此类抑制剂的获得性耐药性问题同时值得关注。靶向胚胎外胚层发育蛋白(embryonic ectoderm development,EED)的两个不同结合位点的药物也在不断向前发展,EZH2-EED PPI抑制剂的研发因全新且独特的作用机制受到广泛关注。本文综述了各类靶向PRC2相关蛋白小分子抑制剂的研究进展,为相关药物的进一步研发提供参考。 展开更多
关键词 表观遗传 多梳抑制复合物2 抑制剂 蛋白-蛋白相互作用 抗肿瘤
原文传递
Plant Long ncRNAs: A New Frontier for Gene Regulatory Control 被引量:9
9
作者 Jian Zhang Hana Mujahid +2 位作者 Yuxuan Hou Babi R. Nallamilli Zhaohua Peng 《American Journal of Plant Sciences》 2013年第5期1038-1045,共8页
Long non-coding RNA (lncRNA) refers to an over 200 nt functional RNA molecule that will not be translated into protein. Previously thought to be dark matters of the genome, lncRNAs have been gradually recognized as cr... Long non-coding RNA (lncRNA) refers to an over 200 nt functional RNA molecule that will not be translated into protein. Previously thought to be dark matters of the genome, lncRNAs have been gradually recognized as crucial gene regulators. Although tremendous progress has been made in animals and human, the study of lncRNAs in plant is still in its infancy. Here, we reviewed the biogenesis and regulation mechanisms of lncRNAs and summarized the achievements that have been made in plant lncRNA identification and functional characterization. Genome-wide identification has uncovered large amount of lncRNAs in Arabidopsis, Rice, Maize and Wheat, and more information from other plant species will be expected with the aid of deep sequencing technologies. Similar to other species, LncRNA-mediated gene regulation also widely exists in plants, even though only a few functionally characterized examples are available. Up to now, at least four divergent lncRNA-mediated regulation mechanisms have been unraveled, including target mimicry, transcription interference, PRC2 associated histone methylation and DNA methylation. lncRNAs may be involved in the regulation of flowering, male sterility, nutrition metabolism, biotic and abiotic stress response in plants. 展开更多
关键词 LONG NON-CODING RNA Plants polycomb REPRESSING Complex 2 Gene Regulation
暂未订购
幽门螺杆菌感染与胃癌中PRC2和H3K27me3的表达关系 被引量:7
10
作者 张宁 曾智 +3 位作者 阎丽萍 杨珂 孙庆文 黄鹏 《中国肿瘤临床》 CAS CSCD 北大核心 2018年第13期667-672,共6页
目的:研究幽门螺杆菌(Helicobacter pylori,HP)感染对胃癌组织中多梳抑制复合物2(polycomb repressive complex 2,PRC2)和组蛋白H3K27me3表达的影响,探索HP感染在胃癌发生过程中的作用。方法:利用快速尿素酶检测、Giemsa染色和PCR方法... 目的:研究幽门螺杆菌(Helicobacter pylori,HP)感染对胃癌组织中多梳抑制复合物2(polycomb repressive complex 2,PRC2)和组蛋白H3K27me3表达的影响,探索HP感染在胃癌发生过程中的作用。方法:利用快速尿素酶检测、Giemsa染色和PCR方法检测复旦大学附属上海市第五人民医院2014年1月至2017年10月行胃癌手术的84例患者HP感染情况,应用免疫组织化学法检测胃癌和癌旁组织PRC2和H3K27me3蛋白的表达,分析两者表达与HP感染之间的相关性。结果:3种方法检测HP感染率分别为70.24%、61.90%和76.19%。PRC2家族成员果蝇zeste基因增强子同源物2(enhancer of zeste homolog 2,EZH2)、SUZ12、EED和H3K27me3蛋白在胃癌组织中的阳性表达率分别为79.76%(67/84)、77.38%(65/84)、40.48%(34/84)和69.05%(58/84),均显著高于癌旁组织(22.62%、34.52%、8.33%和14.29%,P<0.05)。临床资料分析表明,EZH2和H3K27me3蛋白在胃癌中的表达与淋巴结转移呈正相关。在HP阳性胃癌组织中,EZH2、SUZ12、EED和H3K27me3蛋白阳性表达率分别为89.06%(57/64)、84.38%(54/64)、46.88%(30/64)和82.81%(53/64),均显著高于HP阴性胃癌组织(50.00%、55.00%、20.00%和25.00%,P<0.05)。结论:HP感染与胃癌组织中PRC2和H3K27me3蛋白表达上调相关。 展开更多
关键词 幽门螺杆菌 多梳抑制复合物2 果蝇zeste基因增强子同源物2 H3K27me3 胃癌
暂未订购
Polycomb repressive complex 2 in embryonic stem cells:an overview 被引量:2
11
作者 Amanda Jones Hengbin Wang 《Protein & Cell》 SCIE CSCD 2010年第12期1056-1062,共7页
Polycomb Group Proteins(PcG)are a family of epigenetic regulators responsible for the repression of an array of genes important in development and cell fate specification.PcG proteins complex to form two types of epig... Polycomb Group Proteins(PcG)are a family of epigenetic regulators responsible for the repression of an array of genes important in development and cell fate specification.PcG proteins complex to form two types of epigenetic regulators:Polycomb Repressive Complex 1 and 2(PRC1 and PRC2).Although the mechanisms regulating PRC2 recruitment and activity in mammals remain poorly understood,recent work has identified a non-canonical PRC2 in mouse embryonic stem cells(mESC)with unique activities required for repression of PRC2 target genes and necessary for mESC differentiation and somatic cell reprogramming.Here we review the functions of PRC2 in embryonic stem cells and explore the role of the newly identified mESC specific PRC2 regulatory subunits Jarid2(jumonji,AT rich interactive domain 2),Mtf2(metal response element binding transcription factor 2)and esPRC2p48. 展开更多
关键词 polycomb repressive complex 2 histone modification epigenetic regulation
原文传递
Overexpression of enhancer of zests homolog 2 in lymphoma 被引量:4
12
作者 GUO Shan-qi ZHANG Yi-zhuo 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第20期3735-3739,共5页
Objective This article aimed to review the biological characteristics of enhancer of zests homolog 2 (EZH2), and the transcriptional repression mechanism of action of EZH2 in tumors, particularly in the progression ... Objective This article aimed to review the biological characteristics of enhancer of zests homolog 2 (EZH2), and the transcriptional repression mechanism of action of EZH2 in tumors, particularly in the progression of lymphoma. Data sources The data cited in this review were mainly obtained from the articles listed in PubMed and HighWare that were published from March 2004 to April 2012. The search terms were "enhancer of zests homolog 2", "polycomb group", and "lymphoma". Study selection Articles regarding the mechanism of EZH2 in post-transcriptional modification, functions of polycomb group proteins, and the roles of EZH2 in lymphoma were selected. Results EZH2 acts as oncogene and involved in many kinds of tumors. Moreover, it plays an important role in tumorigenesis and lymphomagenesis by promoting the proliferation and aggressiveness of neoplastic cells, facilitating malignant tumor cell diffusion, and mediating transcriptional silencing. Conclusion EZH2 mediated transcriptional repression through its methyltransferase activity at the chromatin level has certain influence on lymphoma, and there might exist a therapeutic window for the development of new agents and identification of novel diagnostic markers based on EZH2. 展开更多
关键词 enhancer of zests homolog 2 polycomb group lymphoma
原文传递
Zeste基因增强子同源物基因2与肿瘤发展的研究进展
13
作者 黄嫄 王晓春 《转化医学杂志》 2016年第6期370-375,共6页
多聚梳抑制复合体2作为一种表观遗传调节因子可选择性催化组蛋白H3第27位赖氨酸三甲基化,从而诱导靶基因转录抑制。Zeste基因增强子同源物2(enhancer of zeste homolog 2,EZH2)是多聚梳抑制复合体2中具有酶活性的亚基,在肿瘤触发、进展... 多聚梳抑制复合体2作为一种表观遗传调节因子可选择性催化组蛋白H3第27位赖氨酸三甲基化,从而诱导靶基因转录抑制。Zeste基因增强子同源物2(enhancer of zeste homolog 2,EZH2)是多聚梳抑制复合体2中具有酶活性的亚基,在肿瘤触发、进展、转移及耐药性方面有重要作用。EZH2与其他表观遗传修饰酶相互协调介导基因沉默,EZH2超表达是多种实体肿瘤晚期和转移性的标志,EZH2的表达与活性受多种肿瘤相关转录因子的调节,各位点氨基酸残基的磷酸化状态可影响EZH2的催化活性,EZH2基因突变在血液系统恶性肿瘤中频繁发生,除通过经典作用即催化抑癌基因启动子区组蛋白H3第27位赖氨酸甲基化来抑制转录外,EZH2还具有诱导基因活化功能。因此,EZH2成为肿瘤治疗的一个理想靶点,其特异性抑制剂EPZ6438正处于临床Ⅰ/Ⅱ期试验阶段。 展开更多
关键词 Zeste基因增强子同源物2 多聚梳抑制复合体2 肿瘤 转录抑制 基因活化
暂未订购
EZH2与癌症 被引量:1
14
作者 唐博瑞 宋檀婧 孙立栋 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2022年第3期415-419,共5页
果蝇zeste基因增强子的人类同源物2(EZH2)编码组蛋白甲基转移酶EZH2,与其他关键蛋白共同组成多梳抑制复合物PRC2,通过催化组蛋白H3第27位赖氨酸的三甲基化发挥转录抑制作用。研究发现,在多种恶性肿瘤细胞中存在EZH2的突变及异常表达,这... 果蝇zeste基因增强子的人类同源物2(EZH2)编码组蛋白甲基转移酶EZH2,与其他关键蛋白共同组成多梳抑制复合物PRC2,通过催化组蛋白H3第27位赖氨酸的三甲基化发挥转录抑制作用。研究发现,在多种恶性肿瘤细胞中存在EZH2的突变及异常表达,这些异常导致了某些抑癌基因的沉默,与癌症的发生、发展、转移、侵袭及预后不良有重要关系。目前,EZH2作为癌症治疗的靶标成为了研究热点,其抑制剂也作为新型癌症靶向药物,投入临床试验及应用。该文对EZH2的肿瘤生物学效应及其在癌症治疗等领域的应用进行综述,以期更加清晰地展示EZH2在肿瘤学领域的研究价值。 展开更多
关键词 EZH2 组蛋白甲基化 转录抑制 癌症 靶向治疗
暂未订购
黑色素瘤相关抗原3、zeste 2多梳抑制复合物2亚基增强子在宫颈癌组织中的表达及与患者预后的关系
15
作者 牛云霞 王越月 王雷 《癌症进展》 2023年第14期1559-1562,1586,共5页
目的 探讨黑色素瘤相关抗原3(MAGEA3)、zeste 2多梳抑制复合物2亚基增强子(EZH2)在宫颈癌组织中的表达及与患者预后的关系。方法 选取45例宫颈癌患者的宫颈癌组织、18例宫颈上皮内瘤变(CIN)患者的CIN组织和17例健康体检者的正常宫颈组织... 目的 探讨黑色素瘤相关抗原3(MAGEA3)、zeste 2多梳抑制复合物2亚基增强子(EZH2)在宫颈癌组织中的表达及与患者预后的关系。方法 选取45例宫颈癌患者的宫颈癌组织、18例宫颈上皮内瘤变(CIN)患者的CIN组织和17例健康体检者的正常宫颈组织,采用免疫组化法检测MAGEA3、EZH2的表达情况。MAGEA3、EZH2表达的相关性采用Spearman相关分析;宫颈癌患者预后的影响因素采用多因素Logistic回归分析。结果 宫颈癌组织中MAGEA3、EZH2的阳性表达率均高于正常宫颈组织和CIN组织,差异均有统计学意义(P﹤0.05)。淋巴结转移、肌层浸润深度﹥1/2、临床分期为ⅡA期、组织学分级为G3级宫颈癌患者宫颈癌组织中MAGEA3、EZH2的阳性表达率分别高于无淋巴结转移、肌层浸润深度≤1/2、临床分期为Ⅰ期、组织学分级为G1~2级的患者,差异均有统计学意义(P﹤0.05)。宫颈癌组织中MAGEA3的表达与EZH2的表达呈正相关(r=0.337,P﹤0.05)。MAGEA3、EZH2阳性表达宫颈癌患者的3年生存率均高于阴性表达患者,差异均有统计学意义(P﹤0.05)。多因素Logistic回归分析结果显示,淋巴结转移、肌层浸润深度﹥1/2、临床分期为ⅡA期、组织学分级为G3级均是宫颈癌患者预后的独立危险因素(P﹤0.05)。结论 MAGEA3、EZH2在宫颈癌组织中表达上调,且阳性表达患者预后较差,淋巴结转移、肌层浸润深度﹥1/2、临床分期为ⅡA期、组织学分级为G3级均是宫颈癌患者预后的独立危险因素。 展开更多
关键词 宫颈癌 黑色素瘤相关抗原3 zeste 2多梳抑制复合物2亚基增强子 预后
暂未订购
多梳蛋白抑制复合物2抑制剂的药物专利分析
16
作者 王萍 《中国新药杂志》 CAS CSCD 北大核心 2022年第5期409-416,共8页
多梳蛋白抑制复合物2(polycomb repressive complex 2,PRC2)具有组蛋白甲基转移酶活性,其亚基包括zeste基因增强子同源物2(enhancer of zeste homologue 2,EZH2)和胚胎外胚层发育蛋白(embryonic ectoderm development,EED),相关小分子... 多梳蛋白抑制复合物2(polycomb repressive complex 2,PRC2)具有组蛋白甲基转移酶活性,其亚基包括zeste基因增强子同源物2(enhancer of zeste homologue 2,EZH2)和胚胎外胚层发育蛋白(embryonic ectoderm development,EED),相关小分子抑制剂的研发成为了当前表观遗传学抗肿瘤策略的热点领域。本文基于PRC2专利文献披露的信息,梳理与分析了2000—2020年PRC2抑制剂的技术发展以及对代表性药物分别进行了核心专利、临床试验和同族专利情况分析,揭示了目前在研的前沿药物发展进度,旨在为科学家和科研管理决策提供科学依据和参考借鉴。 展开更多
关键词 多梳蛋白抑制复合物2 zeste基因增强子同源物2 胚胎外胚层发育蛋白 专利分析 临床试验
原文传递
Polycomblike家族蛋白参与表观遗传调控的分子机制及其生物学意义 被引量:3
17
作者 周海霞 王占新 《中国科学:生命科学》 CSCD 北大核心 2022年第8期1118-1128,共11页
PRC2复合物是Polycomb家族蛋白的重要复合物之一,在细胞的增殖、分化和谱系特征的维持等生理过程中发挥着至关重要的作用.PRC2主要通过修饰染色质和调控染色质结构的方式对基因表达起抑制作用,其中PRC2的核心组分EZH2在组蛋白H3第27位... PRC2复合物是Polycomb家族蛋白的重要复合物之一,在细胞的增殖、分化和谱系特征的维持等生理过程中发挥着至关重要的作用.PRC2主要通过修饰染色质和调控染色质结构的方式对基因表达起抑制作用,其中PRC2的核心组分EZH2在组蛋白H3第27位赖氨酸上留下的三甲基化修饰(H3K27me3)是与基因抑制相关的重要标记之一.PRC2的核心组分需要与其他结合蛋白结合形成全酶才能发挥出最大催化活性.PRC2的结合蛋白,例如Polycomblike(PCL)蛋白,对PRC2的功能起着重要的调控作用.近些年的研究表明,PCL蛋白对PRC2的活性和其在染色质上的招募起着重要的调控作用.此外,PCL蛋白的表达异常与多种人类癌症相关.因此PCL蛋白结构与功能的研究对深入了解其调控PRC2的机制以及靶向PCL相关的药物研发均具重要意义.本文就近年来关于PCL蛋白的结构和功能研究进展进行总结,着重阐述人源PCL蛋白的分子机制和生物学功能. 展开更多
关键词 PCL家族蛋白 表观遗传调控 PRC2复合物 细胞记忆 招募
原文传递
Spatiotemporal expression of Ezh2 in the developing mouse cochlear sensory epithelium
18
作者 Yan Chen Wenyan Li +2 位作者 Wen Li Renjie Chai Huawei Li 《Frontiers of Medicine》 SCIE CAS CSCD 2016年第3期330-335,共6页
The enhancer of zeste 2 polycomb repressive complex 2 subunit (Ezh2) is a histone-lysine N- methyltransferase enzyme that participates in DNA methylation. Ezh2 has also been reported to play crucial roles in stem ce... The enhancer of zeste 2 polycomb repressive complex 2 subunit (Ezh2) is a histone-lysine N- methyltransferase enzyme that participates in DNA methylation. Ezh2 has also been reported to play crucial roles in stem cell proliferation and differentiation. However, the detailed expression profile of Ezh2 during mouse cochlear development has not been investigated. Here, we examined the spatiotemporal expression of Ezh2 in the cochlea during embryonic and postnatal development. Ezh2 expression began to be observed in the whole otocyst nuclei at embryonic day 9.5 (E9.5). At E12.5, Ezh2 was expressed in the nuclei of the cochlear prosensory epithelium. At E13.5 and E15.5, Ezh2 was expressed from the apical to the basal turns in the nuclei of the differentiating cochlear epithelium. At postnatal day (P) 0 and 7, the Ezh2 expression was located in the nuclei of the cochlear epithelium in all three turns and could be clearly seen in outer and inner hair cells, supporting cells, the stria vascularis, and spiral ganglion cells. Ezh2 continued to be expressed in the cochlear epithelium of adult mice. Our results provide the basic Ezh2 expression pattern and might be useful for further investigating the detailed role of Ezh2 during cochlear development. 展开更多
关键词 polycomb repressive complex EZH2 expression inner ear COCHLEA development
原文传递
膀胱尿路上皮癌组织lincRNA差异表达及机制探讨 被引量:1
19
作者 何旺 王沛 +2 位作者 钟广正 黄健 林天歆 《中华肿瘤防治杂志》 CAS 北大核心 2015年第6期421-426,共6页
目的筛选膀胱尿路上皮癌与癌旁组织中差异表达长链基因间非编码RNA(long intergenic noncoding RNA,lincRNA),并探讨其可能作用机制。方法收集2011-01-04-2011-02-18中山大学孙逸仙纪念医院泌尿外科4例膀胱尿路上皮癌与癌旁组织标本并应... 目的筛选膀胱尿路上皮癌与癌旁组织中差异表达长链基因间非编码RNA(long intergenic noncoding RNA,lincRNA),并探讨其可能作用机制。方法收集2011-01-04-2011-02-18中山大学孙逸仙纪念医院泌尿外科4例膀胱尿路上皮癌与癌旁组织标本并应用Trizol提取总RNA,应用基因芯片筛选差异表达的lincRNAs及mRNAs,应用生物信息学分析差异表达lincRNAs和mRNAs特征,应用EZH2抗体和SUZ12抗体进行RNA免疫沉淀筛选与多梳抑制复合物2(PRC2)相互作用的lincRNAs。结果基因芯片筛选发现,共376个lincRNAs及1 284个mRNAs在膀胱尿路上皮癌组织与癌旁组织中存在表达差异(差异倍数≥2.0倍,P<0.05)。lincRNAs表达异常在第1、2、7号染色体最常见,mRNAs差异表达基因的信号通路分析显示,参与细胞间黏附、钙离子信号通路、MAPK信号通路和细胞因子间受体相互作用的基因改变最为明显。与非免疫血清IgG组相比,应用EZH2抗体和SUZ12抗体进行的RNA免疫沉淀提示,HOTAIR分别富集(11.2±1.7)和(9.6±1.1)倍,BX640973分别富集(36.3±2.1)和(14.7±0.8)倍,NR_024344分别富集(30.2±3.5)和(7.7±1.2)倍,LINC312分别富集(5.1±0.4)和(5.7±0.5)倍,NR_036444分别富集(29.5±1.8)和(11.2±0.6)倍,MALAT1分别富集(12.9±1.6)和(25.1±1.5)倍,MEG3分别富集(13.2±0.6)和(4.0±1.3)倍,差异均有统计学意义,P值均<0.05。结论膀胱癌中大量lincRNAs和mRNAs表达发生改变,部分lincRNAs通过与PRC2复合物相互作用发挥功能。 展开更多
关键词 膀胱肿瘤 长链基因间非编码RNA PRC2复合物 RNA-蛋白质相互作用
原文传递
zeste基因增强子同源物2在肿瘤发生中的调控作用
20
作者 姚佳 邹丰 +1 位作者 谢梦佳 赵铁军 《肿瘤研究与临床》 CAS 2020年第11期801-803,共3页
zeste基因增强子同源物2(EZH2)是多梳抑制复合体2(PRC2)的催化亚基,具有组蛋白甲基化转移酶的活性,其在肿瘤的发生、发展、转移和药物耐受等方面扮演了重要的角色。研究发现,EZH2的表达受到多种致癌转录因子、抑癌miRNA、肿瘤相关非编码... zeste基因增强子同源物2(EZH2)是多梳抑制复合体2(PRC2)的催化亚基,具有组蛋白甲基化转移酶的活性,其在肿瘤的发生、发展、转移和药物耐受等方面扮演了重要的角色。研究发现,EZH2的表达受到多种致癌转录因子、抑癌miRNA、肿瘤相关非编码RNA以及多种翻译后修饰的调控,且EZH2对靶基因的沉默作用主要通过介导组蛋白H3第27位赖氨酸的三甲基化修饰(H3K27me3)的发生而实现。文章总结了关于EZH2在肿瘤发生中的主要调控作用及功能,同时综述了EZH2靶向治疗方案的研究进展。 展开更多
关键词 肿瘤 zeste基因增强子同源物2 多梳抑制复合体2
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部